| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |